8Z8V: Human serum albumin

Crystal structure of human serum albumin in complex with ALB8(VHH) domain of ozoralizumab. Determined by X-ray diffraction at 2.05 Å resolution. Released 4 Sept 2024.

Method
X-ray diffraction
Resolution
2.05 Å
Organism
Homo sapiens
Chains
2
Atoms
5,529
Mol. weight
79.71 kDa
Released
4 Sept 2024

Explore 8Z8V in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

8Z8V contains 45 α-helices and 11 β-strands across 2 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 42 helices, 0 β-strands

ElementResiduesLengthSheet
α-helix6-3025
α-helix36-5520
α-helix66-7510
α-helix89-913
α-helix97-1048
α-helix113-1153
α-helix120-12910
α-helix131-14515
α-helix151-16818
α-helix174-20128
α-helix202-2065
α-helix208-22215
α-helix228-24619
α-helix250-26516
α-helix268-2703
α-helix278-2803
α-helix283-29210
α-helix293-2997
α-helix302-3043
α-helix3061
α-helix307-3115
α-helix315-3217
α-helix323-33614
α-helix343-36018
α-helix366-3705
α-helix373-39826
α-helix400-41415
α-helix420-43112
α-helix433-4375
α-helix445-4462
α-helix447-4515
α-helix452-46514
α-helix471-4799
α-helix481-4833
α-helix484-4907
α-helix491-4933
α-helix497-5037
α-helix504-5074
α-helix511-5155
α-helix518-53518
α-helix541-56020
α-helix564-58219
Chain B: 3 helices, 11 β-strands
ElementResiduesLengthSheet
β-strand3-751
β-strand11-1222
β-strand18-2581
α-helix29-313
β-strand34-3963
β-strand46-5163
β-strand58-6033
α-helix62-643
β-strand68-7361
β-strand78-8361
α-helix88-903
β-strand92-9873
β-strand109-11133
β-strand112-11322

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Serum albuminAprotein585Homo sapiensP02768 (AlphaFold model)
ALB8:VHHBprotein123Homo sapiens
Sequence of entity 1 (A), FASTA
>8Z8V_1 Serum albumin (chains A)
DAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAE
NCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEV
DVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLP
KLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTK
VHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPA
DLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKC
CAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVST
PTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTES
LVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKAT
KEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL
Sequence of entity 2 (B), FASTA
>8Z8V_2 ALB8:VHH (chains B)
EVQLVESGGGLVQPGNSLRLSCAASGFTFSSFGMSWVRQAPGKGLEWVSSISGSGSDTLY
ADSVKGRFTISRDNAKTTLYLQMNSLRPEDTAVYYCTIGGSLSRSSQGTLVTVSSTSHHH
HHH

Primary citation

Structural design of the anti-TNF alpha therapeutic NANOBODY® compound, ozoralizumab, to support its potent and sustained clinical efficacy. Mima, M., Mishima-Tsumagari, C., Nakano, K. et al. Biochem Biophys Res Commun (2024) 734:150454-150454. DOI 10.1016/j.bbrc.2024.150454 · PubMed

Other PDB entries of the same protein (UniProt P02768 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 8Z8V directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.